| J9271 | Injection, pembrolizumab, 1 mg | 6,000 | $40 | $246K |
| J0897 | Injection, denosumab, 1 mg | 7,200 | $20 | $136.8K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 46,150 | $1 | $92.3K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 610 | $80 | $49K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 460 | $80 | $35.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 240 | $110 | $27.1K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 200 | $130 | $25K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 17,250 | $1 | $17.3K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 260 | $60 | $15.4K |
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 600 | $20 | $13.8K |